NACCME

Understanding CTD-PAH: An Overview

Exploring the Role of JAK Inhibitors Across the Spectrum of IMIDs

The Role of Factor Xa Anticoagulation in CLI

Screening Mandates for Patients with CTD: Improving PAH Identification

Management of Pulmonary Arterial Hypertension in Primary Care: Advancing Patient Outcomes

Advancing the Multidisciplinary Management of Hepatocellular Carcinoma

Rheumatoid Arthritis: Real-World Experience and Emerging Insights into DMARD Monotherapy

Treat-to-Target in IBD: Decreasing Inflammation & Achieving Mucosal Healing

Reducing Clinical Inertia in Type 2 Diabetes: A Case for Early Combination Therapy

Optimizing Outcomes in Adult ADHD: Addressing Diagnostic and Treatment Challenges

BRCA+ Pancreatic Cancer Maintenance Debate: PARP Inhibitor or Continued Chemo? - PARP Inhibitor

Basics of Immunotherapy in NSCLC

Applying Appropriate Use Criteria for Cardiac Imaging: Improving CHD Screening and Diagnosis

Demystifying the Nature of Biofilms

Current controversies in Small Cell Lung Cancer (SCLC)

Incorporating Long-Acting Insulin Therapy into the Physiologic Approach to Diabetes Management

Fixed Ratio GLP-1 RA and Basal Insulin Combinations: Role in Treatment Intensification

Utilizing Clinical Pathways for Remission Maintenance in Ovarian Cancer

Aligning Diabetes Practice to High-Quality, Value-Based Care

Critical Limb Ischemia: The Emerging Use of Parametric Imaging

The Burden of CTD-PAH: Patient Perspectives

Children with Chronic Illness: Transition Issues

Complex Coronary Lesions: The Emerging Role of Drug Eluting Stents

Pressure Injury Prevention and Treatment: Optimizing Healing through Nutrition and Lean Body Mass